Edita Food Industries - Summary of Resolutions of the Board of Directors Meeting of the company convened on 26/2/2023.

Cairo, 27/2/2023

Edita Food Industries SAE ("the Company") announces that the Board of Directors Meeting of the Company convened on 26/2/2023 and unanimously resolved the following resolutions:

1) The Board of Directors unanimously approved the minutes of the previous Board of Directors Meeting No. (167) dated 10/1/2023.

2) The Board of Directors unanimously approved the offer to acquire 100% of the issued share capital of a company not listed on the Egyptian Stock Exchange and undertaking food industry activities, as well as authorizing Eng. Hani Nabih Aziz Berzi - Chairman of the Board of Directors or his representative to submit and determine the terms of the offer, sign the offer and take the necessary procedures and approvals required in accordance with the relevant laws, noting that the execution of the acquisition transaction is conditional upon the completion of all legal and regulatory requirements.

3) The Board of Directors unanimously approved the authorization of Eng. Hani Nabih Aziz Berzi - Chairman of the Board of Directors to appoint an independent financial advisor registered in the FRA, determine his fees, sign the relevant contracts and take the necessary measures in accordance with Article (44) of the Listing Rules.

-Ends

Contacts

Ms. Menna Shams El Din

Head of IR& Corporate Affairs

T: +202 3851 6464 | M: +20 100 1542428 | menna.shamseldin@edita.com.eg

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END